CRVS: Corvus Pharmaceuticals, Inc. Stock

by  •  • Comments Off on CRVS: Corvus Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 274.72
Enterprise Value ($M) 230.51
Book Value ($M) 49.33
Book Value / Share 0.72
Price / Book 5.57
NCAV ($M) 34.10
NCAV / Share 0.50
Price / NCAV 8.06

Profitability (mra)
Return on Invested Capital (ROIC) -0.81
Return on Assets (ROA) -1.03
Return on Equity (ROE) -1.24

Liquidity (mrq)
Quick Ratio 4.93
Current Ratio 4.93

Balance Sheet (mrq) ($M)
Current Assets 44.21
Assets 59.44
Liabilities 10.11
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -27.55
Net Income -62.29
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -25.42
Cash from Investing -27.48
Cash from Financing 49.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-15 13G/A Samlyn Capital, Llc 6.00 -39.01
05-14 13D/A Orbimed Advisors Llc 12.20 0.00
02-13 13G/A Miller Richard A Md 7.70 41.70
2024-05-09 13G Point72 Asset Management, L.P. 9.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2025-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-02 194,678 732,393 26.58
2025-05-30 107,857 463,739 23.26
2025-05-29 146,313 636,540 22.99
2025-05-28 185,250 569,934 32.50

(click for more detail)

Similar Companies
CRMD – CorMedix Inc. CRON – Cronos Group Inc.
CRSP – CRISPR Therapeutics AG CURR – CURRENC Group Inc.
CVAC – CureVac N.V.


Financial data and stock pages provided by
Fintel.io